Clinical Trials for DLL3-expressing Tumors

Find clinical trials for dll3-expressing tumors. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

NCT ID: NCT06788938

This clinical trial is studying a new cancer treatment called tarlatamab for patients with advanced tumors that express a protein known as DLL3. The main goal is to find out how effective tarlatama...

Recruiting

Phase: PHASE2 Type: interventional Locations: Los Angeles, California, United States, San Francisco, California, United States +3 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions